Review of the rational use and adverse reactions to human serum albumin in the People's Republic of China

Patient Preference and Adherence

Volumn 7, Issue , 2013, Pages 1207-1212

  Zhou, Ting ^a   Lu, Saihua ^a   Liu, Xiufeng ^a   Zhang, Ye ^a   Xu, Feng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

ADR; Albumin; HSA; Hypoproteinemia; Off label use; Plasma substitute

Indexed keywords

HUMAN SERUM ALBUMIN;

ADOLESCENT; ADULT; ADVERSE OUTCOME; ALLERGIC REACTION; ANAPHYLACTIC SHOCK; CHINA; CONVULSION; DRUG SAFETY; FEMALE; HEART FAILURE; HEMOLYSIS; HUMAN; INFANT; INFUSION RATE; INJECTION SITE IRRITATION; KIDNEY INJURY; LARYNX SWELLING; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MENTAL DISEASE; OFF LABEL DRUG USE; OUTCOME ASSESSMENT; PAROTID GLAND SWELLING; PATIENT SAFETY; RATING SCALE; REVIEW; SEX DIFFERENCE; SWELLING;

EID: 84888618453     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S53484     Document Type: Review

References (35)

1. Fanali G, di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P. Human serum albumin: from bench to bedside. Mol Aspects Med. 2012;33(3): 209-290.
2. Mendez CM, McClain CJ, Marsano LS. Albumin therapy in clinical practice. Nutr Clin Pract. 2005;20(3):314-320.
3. Doweiko JP, Nompleggi DJ. Use of albumin as a volume expander. JPEN J Parenter Enteral Nutr. 1991;15(4):484-487.
4. Margarson MP, Soni N. Serum albumin: touchstone or totem? Anaesthesia. 1998;53(8):789-803.
5. Liberati A, Moja L, Moschetti I, Gensini GF, Gusinu R. Human albumin solution for resuscitation and volume expansion in critically ill patients. Intern Emerg Med. 2006;1(3):243-245.
6. Liumbruno GM, Bennardello F, Lattanzio A, Piccoli P, Rossettias G; Italian Society of Transfusion Medicine and Immunohaematology (SIMTI). Recommendations for the use of albumin and immunoglobulins. Blood Transfus. 2009;7(3):216-234.
7. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmac Ther. 1981;30:239-245.
8. von Hoegen I, Waller C. Safety of human albumin based on spontaneously reported serious adverse events. Crit Care Med. 2001;29(5):994-996.
9. Vincent JL, Wilkes MM, Navickis RJ. Safety of human albumin - serious adverse events reported worldwide in 1998-2000. Br J Anaesth. 2003;91(5):625-630.
10. Vincent JL. Resuscitation using albumin in critically ill patients: research in patients at high risk of complications is now needed. BMJ. 2006;333(7577):1029-1030.
11. Vermeulen LC, Ratko TA, Erstad BL, Brecher ME, Matuszewski KA. A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Arch Intern Med. 1995;155(4):373-379.
12. University HealthSystem Consortium. Technology assessment: albumin, non-protein colloid, and crystalloid solutions. Oak Brook; University Health System Consortium: 2000.
13. Prinoth O, Strada P. Proposta di linee guida al corretto uso dell'albumina [Proposal for guidelines on the correct use of albumin]. Il Servizio Trasfusionale. 2002;3:5-10. Italian.
14. Vermeulen LC, Ratko TA, Erstad BL, Brecher ME, Matuszewski KA. A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Arch Intern Med. 1995;155(4):373-379.
15. Fleck A, Raines G, Hawker F, et al. Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet. 1985;1(8432):781-784.
16. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients [review]. Cochrane Database Syst Rev. 2007:CD000567.
17. Quinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. Hepatology. 2005; 41:1211-1219.
18. Evans TW. Review article: albumin as a drug-- biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol Ther. 2002;16 (Suppl 5):6-11.
19. Naderi M, Eshghi P, Saneei Moghaddam E, et al. Safety of human blood products in rare bleeding disorders in southeast of Iran. Haemophilia. 2013;19(2):e90-e92.
20. Yamey G. Albumin industry launches global promotion. BMJ. 2000;320(7234):533.
21. Van Liedekerke BM, Nelis HJ, Kint JA, Vanneste FW, De Leenheer AP. Quality control of albumin solutions by size-exclusion high-performance liquid chromatography, isoelectric focusing, and two-dimensional immunoelectrophoresis. J Pharm Sci. 1991;80(1):11-16.
22. Grgicevic D. Blood safety. Nat Med. 1995;1(6):493.
23. Wang MY. Two fatal allergic reactions caused by human serum albumin. China Pharmaceuticals. 2011;20:83.
24. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ. 1998;317(7153):235-240.
25. Wilkes MM, Navickis RJ. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med. 2001;135(3):149-164.
26. Offringa M, Gemke RJ, Henny CP. [Excess mortality in critically ill patients after treatment with human albumin]. Ned Tijdschr Geneeskd. 1998;142(33):1855-1858. Dutch.
27. Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth. 2000;85(4):599-610.
28. Aramwit P, Kasettratat N. Evaluation of serum albumin utilization in inpatient at a private hospital in Bangkok. Yakugaku Zasshi. 2004;124(9):631-634.
29. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R; SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350(22): 2247-2256.
30. Alderson P, Bunn F, Lefebvre C, et al; Albumin Reviewers. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev. 2004:CD001208.
31. Liberati A, Moja L, Moschetti I, Gensini GF, Gusinu R. Human albumin solution for resuscitation and volume expansion in critically ill patients. Intern Emerg Med. 2006;1(3):243-245.
32. Roberts I, Blackhall K, Alderson P, Bunn F, Schierhout G. Human albumin solution for resuscitation and volume expansion in critically ill patients [review]. Cochrane Database Syst Rev. 2011:CD001208.
33. Mirici-Cappa F, Caraceni P, Domenicali M, et al. How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure. World J Gastroenterol. 2011;17(30):3479-3486.
34. Sikuler E, Shapira A, Mor-Yosef S, et al. [Rational use of albumin]. Harefuah. 2000;139(5-6):190-3, 246. Hebrew.
35. Woodman R. Doctors advised to take special care with human albumin. BMJ. 1999;318(7199):1643.